Hasil Pencarian - Gee-Chen Chang
- Menampilkan 1 - 20 hasil dari 42
- Ke Halaman Berikutnya
-
1
A novel tool to evaluate and quantify radiation pneumonitis: A retrospective analysis of correlation of dosimetric parameters with volume of pneumonia patch oleh Jing-Wen Huang, Jing-Wen Huang, Yi-Hui Lin, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Jeremy J. W. Chen
Diterbitkan 2023-03-01
Artikel -
2
An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan oleh Shang-Gin Wu, Shang-Gin Wu, Chi-Lu Chiang, Chi-Lu Chiang, Chi-Lu Chiang, Chien-Ying Liu, Chin-Chou Wang, Po-Lan Su, Te-Chun Hsia, Jin-Yuan Shih, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang
Diterbitkan 2020-09-01
Artikel -
3
Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers oleh Sheng-Kai Liang, Sheng-Kai Liang, Li-Hsin Chien, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Ying-Huang Tsai, Wu-Chou Su, Yuh-Min Chen, Ming-Shyan Huang, Hsien-Chih Lin, Wen-Tsen Fang, Hsiao-Han Hung, Shih-Sheng Jiang, Chih-Yi Chen, Kuan-Yu Chen, I-Shou Chang, I-Shou Chang, Chao A. Hsiung, Chien-Jen Chen, Chien-Jen Chen, Pan-Chyr Yang, Pan-Chyr Yang, the GELAC Study Group
Diterbitkan 2021-09-01
Artikel -
4
-
5
-
6
Hybrid Pharmacophore- and Structure-Based Virtual Screening Pipeline to Identify Novel EGFR Inhibitors That Suppress Non-Small Cell Lung Cancer Cell Growth oleh Chia-Wei Weng, Chi-Hsuan Wei, Jeng-Yuan Tsai, Yi-Hua Lai, Gee-Chen Chang, Jeremy J. W. Chen
Diterbitkan 2022-03-01
Artikel -
7
-
8
Exercise experiences in patients with metastatic lung cancer: A qualitative approach. oleh Pi-Hua Chang, Ching-Rong Lin, Yun-Hsiang Lee, Yi-Lin Liu, Gee-Chen Chang, Aasha I Hoogland, Yeur-Hur Lai
Diterbitkan 2020-01-01
Artikel -
9
Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma oleh Po-Hsin Lee, Po-Hsin Lee, Po-Hsin Lee, Po-Hsin Lee, Chun-Ju Chiang, Chun-Ju Chiang, Jeng-Sen Tseng, Jeng-Sen Tseng, Jeng-Sen Tseng, Jeng-Sen Tseng, Zhe-Rong Zheng, Zhe-Rong Zheng, Zhe-Rong Zheng, Kun-Chieh Chen, Kun-Chieh Chen, Cheng-Hsiang Chu, Cheng-Hsiang Chu, Yen-Hsiang Huang, Yen-Hsiang Huang, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Wen-Chung Lee, Wen-Chung Lee, Tsung-Ying Yang, Tsung-Ying Yang, Tsang-Wu Liu, Jiun-Yi Hsia, Jiun-Yi Hsia, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang
Diterbitkan 2023-02-01
Artikel -
10
Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naïve ALK-positive advanced lung adenocarcinoma oleh Zhe-Rong Zheng, Zhe-Rong Zheng, Zhe-Rong Zheng, Hsiu-Ying Ku, Kun-Chieh Chen, Kun-Chieh Chen, Chun-Ju Chiang, Chun-Ju Chiang, Chih-Liang Wang, Chih-Liang Wang, Chih-Yi Chen, Chih-Yi Chen, Chun-Ming Tsai, Ming-Shyan Huang, Ming-Shyan Huang, Ming-Shyan Huang, Chong-Jen Yu, Chong-Jen Yu, Chong-Jen Yu, Jin-Shing Chen, Jin-Shing Chen, Jin-Shing Chen, Teh-Ying Chou, Teh-Ying Chou, Wen-Chung Lee, Wen-Chung Lee, Chun-Chieh Wang, Tsang-Wu Liu, Jiun-Yi Hsia, Jiun-Yi Hsia, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang, Gee-Chen Chang
Diterbitkan 2023-03-01
Artikel -
11
ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies oleh Yi-Ming Chen, Der-Yuan Chen, Kuo-Tung Tang, Yen-Hsiang Huang, Jeremy J W Chen, Tsung-Ying Yang, Gee-Chen Chang
Diterbitkan 2021-12-01
Artikel -
12
Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced <i>EGFR</i>-Mutant Lung Adenocarcinoma oleh Po-Hsin Lee, Yen-Hsiang Huang, Ho Lin, Kuo-Hsuan Hsu, Kun-Chieh Chen, Jeng-Sen Tseng, Gee-Chen Chang, Tsung-Ying Yang
Diterbitkan 2022-07-01
Artikel -
13
-
14
Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer. oleh Sheng-Yi Lin, Hsiu-Hui Chang, Yi-Hua Lai, Ching-Hsiung Lin, Min-Hsuan Chen, Gee-Chen Chang, Meng-Feng Tsai, Jeremy J W Chen
Diterbitkan 2015-01-01
Artikel -
15
Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer oleh Jin-Yuan Shih, Yung-Hung Luo, Gee-Chen Chang, John Wen-Cheng Chang, Chin-Chou Wang, Tsung-Ying Yang, Wei-Tse Fang, Wen-Yi Shau
Diterbitkan 2024-08-01
Artikel -
16
Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy. oleh Jen-Yi Lee, Yee-Ming Lee, Gee-Chen Chang, Sung-Liang Yu, Wan-Yu Hsieh, Jeremy J W Chen, Huei-Wen Chen, Pan-Chyr Yang
Diterbitkan 2011-01-01
Artikel -
17
-
18
Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma. oleh Kang-Yi Su, Jeng-Sen Tseng, Keng-Mao Liao, Tsung-Ying Yang, Kun-Chieh Chen, Kuo-Hsuan Hsu, Pan-Chyr Yang, Sung-Liang Yu, Gee-Chen Chang
Diterbitkan 2018-01-01
Artikel -
19
Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors oleh Po-Hsin Lee, Tsung-Ying Yang, Kun-Chieh Chen, Yen-Hsiang Huang, Jeng-Sen Tseng, Kuo-Hsuan Hsu, Yu-Chen Wu, Ko-Jiunn Liu, Gee-Chen Chang
Diterbitkan 2021-04-01
Artikel -
20
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M oleh Yen-Hsiang Huang, Jeng-Sen Tseng, Kuo-Hsuan Hsu, Kun-Chieh Chen, Kang-Yi Su, Sung-Liang Yu, Jeremy J. W. Chen, Tsung-Ying Yang, Gee-Chen Chang
Diterbitkan 2021-08-01
Artikel